Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Novartis at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Novartis brings 1 presentation to SITC 2026 in Phoenix. Its program focuses on bringing the patient advocate perspective into research, including how to write a lay abstract. On the science side, it covers combining immunotherapy with radiopharmaceuticals or radiation therapy.

Organization

SITC 2026 Attendance

Novartis

Basel, Switzerland

novartis.com

Large pharma

Swiss pharmaceutical company whose oncology medicines include radioligand therapies and CAR T-cell therapy.

Session

Thu Nov 5
4:05pm–4:30pm

The Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates

Encanto AB

Clinical

Talk

Thu Nov 5
4:30pm–5:00pm

Part of Session II – Breakout Sessions

Breakout Table: Writing a Lay Abstract

Encanto AB

Session

Sat Nov 7
3:30pm–4:50pm

Novel Paradigms for Effectively Combining Immunotherapies with Radiopharmaceuticals or Radiation Therapy

301BC

Clinical

3:30pm–3:45pmNavigating the Irradiated TME: Targeting Distinct Suppressive Axes to Restore EfficacyWashington University in St. Louis
3:45pm–4:00pmDistinct Immune Responses Induced by Different Forms of Radiotherapy Combined with Immune Checkpoint InhibitionFred Hutchinson Cancer Center
4:00pm–4:15pmRadioligand Therapy + Immunotherapy: Translating Biology to BenefitPeter MacCallum Cancer Centre
4:15pm–4:30pmIntratumoral Injectables Paired with Radiation TherapyUCLA
4:30pm–4:44pm2 abstract presentations — titles not yet released

Instantly find 20 buyers from Novartis

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction